Nutriflex Omega 56/144 S

Valine, Alanine, Arginine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serine, Threonin, the active ingredient in Nutriflex Omega 56/144 S, is an amino acid mixture presented as a parenteral nutrition solution for intravenous use. It provides essential amino acids to patients requiring nutritional support, particularly in critical care and postoperative settings.

GNH USA supplies Nutriflex Omega 56/144 S as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Nutriflex Omega 56/144 S is used as part of parenteral nutrition regimens for patients who cannot meet protein and amino‑acid requirements orally. - Critical illness: supports protein synthesis and nitrogen balance in intensive‑care patients. - Post‑operative recovery: aids wound healing and tissue repair after major surgery. - Severe malnutrition: supplies essential amino acids when oral intake is insufficient or contraindicated.

Adverse reactions are generally related to the intravenous route and the amino‑acid composition.

Common Side Effects: - Mild infusion site erythema: localized redness at the catheter site. - Transient nausea: brief episodes of nausea during or shortly after infusion. - Hyperglycaemia: temporary rise in blood glucose levels, especially in diabetic patients. - Electrolyte shifts: mild changes in serum potassium or phosphate. - Headache: occasional mild headache during treatment.

Serious or Rare Side Effects: - Anaphylactic reaction: severe allergic response requiring immediate medical intervention. - Severe hyperammonemia: marked increase in blood ammonia levels. - Metabolic acidosis: significant drop in blood pH. - Hepatic dysfunction: abnormal liver enzyme elevations. - Renal impairment: worsening kidney function in susceptible individuals.

When prescribing Nutriflex Omega 56/144 S, clinicians should consider patient‑specific factors and monitor relevant parameters. - Renal function: assess creatinine clearance before initiation and during therapy. - Hepatic status: evaluate liver enzymes and function tests. - Metabolic disorders: monitor glucose and electrolyte levels regularly. - Allergic history: verify absence of known hypersensitivity to any amino‑acid component. - Infusion rate: adhere to recommended infusion speeds to minimise phlebitis. - Store at 2‑8°C: keep refrigerated, protect from light, do not freeze or shake.

Amino‑acid solutions may interact with certain medications or clinical conditions.

Major Interactions (Avoid): - High‑dose potassium supplements: can exacerbate hyperkalaemia when combined. - Certain antibiotics (e.g., aminoglycosides): may increase nephrotoxic risk.

Moderate Interactions (Monitor Closely): - Insulin therapy: may require dose adjustment due to glucose fluctuations. - Loop diuretics: monitor electrolyte balance, especially potassium and magnesium. - Anticonvulsants (e.g., valproate): may alter plasma amino‑acid levels. - Corticosteroids: can affect protein catabolism rates. - Total parenteral nutrition admixtures: ensure compatibility before co‑administration.